Podwise 處理的新節目，隨時可搜尋、瀏覽，並在完整應用中繼續。
在按下播放前，先讀讀每集講了什麼。
AI 摘要 Loneliness functions as a vital biological signal, akin to boredom, that alerts individuals to unmet social needs or necessary life transitions. Rather than viewing it as an inescapable modern epidemic, it should be understood as a natural response to shifting social structures…
32 minEnglish摘要 · 逐字稿
AI 摘要 Mike Milken’s pioneering role in the high-yield debt market serves as a blueprint for challenging conventional financial wisdom and fostering industry consolidation. His approach—utilizing simple, Socratic questioning to shift entrenched perspectives—highlights the necessity for…
10:53English摘要 · 逐字稿
AI 摘要 康方生物及其核心药物依沃西单抗的临床表现与全球化进程，是当前创新药领域的核心议题。依沃西单抗通过双特异性抗体机制，在多项中国临床试验（如 HARMONi-2 和 HARMONi-6）中展现出优于传统 PD-1 抑制剂的疗效，成功改写了肺癌治疗标准。然而，其全球多中心临床试验面临人群差异、统计学门槛及执行一致性等多重挑战，导致市场预期出现显著波动。尽管与 Summit…
01:03:13Chinese摘要 · 逐字稿
AI 摘要 Jensen Huang’s sudden resignation as Nvidia CEO dominates the industry conversation, sparking intense speculation regarding the underlying causes, ranging from alleged Chinese espionage to internal leadership transitions. Amidst this turmoil, the AI landscape continues to evolve…
English摘要 · 逐字稿
AI 摘要 Manus 的发展历程折射出 AI 创业公司在复杂地缘政治与监管博弈中的生存困境。作为一家 AI Agent 产品公司，Manus 在获得硅谷风投 Benchmark 投资后，迅速遭遇美国 “反向 CFIUS” 审查，被迫将总部迁至新加坡以规避风险。随后，Meta 对其发起的收购引发了中国商务部关于技术出口的国家安全审查，最终导致交易撤销并由中资机构回购。这一系列跌宕起伏的资本运作与监管干预，不仅揭示了中美科技竞赛下 “科技回流” 的政策暗线，也为寻求全球化发展的创业者提供了关于政治敏感性与合规边界的深刻警示。Manus 的经历证明，在 AI…
45 minChinese摘要 · 逐字稿
AI 摘要 Artificial intelligence is evolving into a potential "global brain," a superintelligence that may eventually possess governing authority. This technological shift demands a new, cohesive international framework to manage existential risks, such as the development of bioweapons…
00:51:31English摘要 · 逐字稿
Wealthion - Be Financially Resilient
The Proof with Simon Hill
The Art of Charm
The Rest Is Money
Motley Fool Hidden Gems Investing
The Journal.
Totally Booked with Zibby
The Art of Accomplishment
Thoughts on the Market
How Long Gone
Fashion People
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
